Department of Otolarygology Head and Neck Surgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences,Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China
Department of Otorhinolaryngology, Shanxi Provincial People's Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China.
BMJ Open. 2021 Oct 13;11(10):e050387. doi: 10.1136/bmjopen-2021-050387.
Laryngeal cancer is the most prevalent entity of head and neck cancer. Knowing the trends of incidence and mortality of laryngeal cancer is important for the reduction in related disease burden.
Population-based observational study.
The incidence and mortality data of laryngeal cancer were retrieved from the Global Burden of Disease study 2017 online database. The estimated average percentage change was used to quantify the trends of laryngeal cancer incidence and mortality at the global, regional and national levels.
Globally, the numbers of incident cases and deaths due to laryngeal cancer increased 58.7% and 33.9%, respectively, from 1990 to 2017. However, the overall age-standardised incidence rate (ASIR) and age-standardised mortality rate decreased by 0.99% (95% CI 0.83% to 1.14%) and 1.62% (95% CI 1.50% to 1.74%) per year, respectively. These decreases were ubiquitous worldwide. However, unfavourable trends in the ASIR of laryngeal cancer were also observed in a total of 51 developing countries.
The incidence and mortality rates of laryngeal cancer have significantly decreased at the global level and in most countries over the past three decades. The regions that showed an increasing incidence trend deserve more attention.
喉癌是头颈部癌症中最常见的实体瘤。了解喉癌的发病率和死亡率趋势对于降低相关疾病负担非常重要。
基于人群的观察性研究。
从 2017 年全球疾病负担研究在线数据库中检索到喉癌的发病率和死亡率数据。使用估计的平均百分比变化来量化全球、区域和国家各级喉癌发病率和死亡率的趋势。
全球范围内,1990 年至 2017 年,喉癌新发病例和死亡人数分别增加了 58.7%和 33.9%。然而,总体年龄标准化发病率(ASIR)和年龄标准化死亡率每年分别下降 0.99%(95%CI 0.83%至 1.14%)和 1.62%(95%CI 1.50%至 1.74%)。这些下降在全球范围内普遍存在。然而,在过去的三十年中,共有 51 个发展中国家的喉癌 ASIR 呈不利趋势。
在过去的三十年中,全球范围内和大多数国家的喉癌发病率和死亡率都显著下降。发病率呈上升趋势的地区需要更多关注。